Natco Pharma Ltd
NSE:NATCOPHARM

Watchlist Manager
Natco Pharma Ltd Logo
Natco Pharma Ltd
NSE:NATCOPHARM
Watchlist
Price: 1 376.55 INR 0.7% Market Closed
Market Cap: 246.6B INR
Have any thoughts about
Natco Pharma Ltd?
Write Note

Natco Pharma Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Natco Pharma Ltd
Operating Income Peer Comparison

Comparables:
DRREDDY
CIPLA
SUNPHARMA
T
TORNTPHARM
M
MANKIND

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Natco Pharma Ltd
NSE:NATCOPHARM
Operating Income
â‚ą18.4B
CAGR 3-Years
63%
CAGR 5-Years
22%
CAGR 10-Years
28%
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Operating Income
â‚ą65B
CAGR 3-Years
28%
CAGR 5-Years
27%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Operating Income
â‚ą56.2B
CAGR 3-Years
17%
CAGR 5-Years
21%
CAGR 10-Years
14%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Operating Income
â‚ą112.5B
CAGR 3-Years
13%
CAGR 5-Years
17%
CAGR 10-Years
4%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Operating Income
â‚ą27.8B
CAGR 3-Years
14%
CAGR 5-Years
14%
CAGR 10-Years
10%
M
Mankind Pharma Ltd
NSE:MANKIND
Operating Income
â‚ą21.5B
CAGR 3-Years
11%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Natco Pharma Ltd's Operating Income?
Operating Income
18.4B INR

Based on the financial report for Jun 30, 2024, Natco Pharma Ltd's Operating Income amounts to 18.4B INR.

What is Natco Pharma Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
28%

Over the last year, the Operating Income growth was 104%. The average annual Operating Income growth rates for Natco Pharma Ltd have been 63% over the past three years , 22% over the past five years , and 28% over the past ten years .

Back to Top